全文获取类型
收费全文 | 1467篇 |
免费 | 42篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 73篇 |
妇产科学 | 18篇 |
基础医学 | 228篇 |
口腔科学 | 11篇 |
临床医学 | 147篇 |
内科学 | 416篇 |
皮肤病学 | 24篇 |
神经病学 | 52篇 |
特种医学 | 59篇 |
外科学 | 242篇 |
综合类 | 36篇 |
预防医学 | 94篇 |
眼科学 | 5篇 |
药学 | 44篇 |
中国医学 | 1篇 |
肿瘤学 | 55篇 |
出版年
2023年 | 60篇 |
2022年 | 124篇 |
2021年 | 128篇 |
2020年 | 146篇 |
2019年 | 45篇 |
2018年 | 39篇 |
2017年 | 34篇 |
2016年 | 72篇 |
2015年 | 48篇 |
2014年 | 101篇 |
2013年 | 58篇 |
2012年 | 47篇 |
2011年 | 38篇 |
2010年 | 95篇 |
2009年 | 85篇 |
2008年 | 46篇 |
2007年 | 30篇 |
2006年 | 23篇 |
2005年 | 19篇 |
2004年 | 14篇 |
2003年 | 23篇 |
2002年 | 20篇 |
2001年 | 18篇 |
2000年 | 20篇 |
1999年 | 20篇 |
1998年 | 25篇 |
1997年 | 17篇 |
1996年 | 16篇 |
1995年 | 11篇 |
1994年 | 12篇 |
1993年 | 12篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 3篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1975年 | 4篇 |
1974年 | 2篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有1518条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
《Vaccine》2020,38(51):8185-8193
BackgroundWhile administration of the measles-mumps-rubella (MMR-II®) vaccine has been effective at preventing rubella infection in the United States, the durability of humoral immunity to the rubella component of MMR vaccine has not been widely studied among older adolescents and adults.MethodsIn this longitudinal study, we sought to assess the durability of rubella virus (RV)-specific humoral immunity in a healthy population (n = 98) of adolescents and young adults at two timepoints: ~7 and ~17 years after two doses of MMR-II® vaccination. Levels of circulating antibodies specific to RV were measured by ELISA and an immune-colorimetric neutralization assay. RV-specific memory B cell responses were also measured by ELISpot.ResultsRubella-specific IgG antibody titers, neutralizing antibody titers, and memory B cell responses declined with increasing time since vaccination; however, these decreases were relatively moderate. Memory B cell responses exhibited a greater decline in men compared to women.ConclusionsCollectively, rubella-specific humoral immunity declines following vaccination, although subjects’ antibody titers remain well above the currently recognized threshold for protective immunity. Clinical correlates of protection based on neutralizing antibody titer and memory B cell ELISpot response should be defined. 相似文献
5.
6.
7.
8.
9.
S. Furusho S. Myou M. Fujimura T. Kita M. Yasui K. Kasahara S. Nakao K. Takehara S. Sato 《Clinical and experimental allergy》2006,36(10):1294-1302
BACKGROUND: Adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) are thought to contribute to the airway inflammation and airway hyper-responsiveness (AHR) of allergic asthma. Some differences from allergic asthma have been noted, including airway neutrophilia, and the involvement of ICAM-1 in toluene diisocyanate (TDI) asthma is currently unclear. OBJECTIVE: We utilized mice lacking ICAM-1 expression (ICAM-1(-/-)) to investigate the role of ICAM-1 in airway inflammation and AHR in TDI-induced asthma. METHODS: Male C57BL/6J mice (ICAM-1(+/+)) and ICAM-1(-/-) mice were intranasally sensitized to TDI solution or solvent alone. Airway inflammation, AHR and cytokine secretion were assessed 24 h after challenge by TDI or solvent. The production of antigen-specific IgG and IgE by TDI sensitized and non-sensitized mice was determined. RESULTS: TDI challenge to ICAM-1(+/+) mice induced an increase in airway inflammatory cell numbers, AHR and cytokine secretion of TNF-alpha, macrophage inflammatory protein-2 (MIP-2), IL-4, IL-5 and IFN-gamma into the bronchoalveolar lavage fluid. All these pathophysiological changes were reduced in ICAM-1(-/-) mice. Serum levels of TDI-specific IgG and IgE of ICAM-1(-/-) and ICAM-1(+/+) mice were comparable. CONCLUSION: These results suggest that ICAM-1 plays an essential role in airway inflammation and AHR in TDI-induced asthma. 相似文献
10.
Wells GD Plyley M Thomas S Goodman L Duffin J 《European journal of applied physiology》2005,94(5-6):527-540
The efficiency of the respiratory system presents significant limitations on the bodys ability to perform exercise due to the effects of the increased work of breathing, respiratory muscle fatigue, and dyspnoea. Respiratory muscle training is an intervention that may be able to address these limitations, but the impact of respiratory muscle training on exercise performance remains controversial. Therefore, in this study we evaluated the effects of a 12-week (10 sessions week–1) concurrent inspiratory and expiratory muscle training (CRMT) program in 34 adolescent competitive swimmers. The CRMT program consisted of 6 weeks during which the experimental group (E, n=17) performed CRMT and the sham group (S, n=17) performed sham CRMT, followed by 6 weeks when the E and S groups performed CRMT of differing intensities. CRMT training resulted in a significant improvement in forced inspiratory volume in 1 s (FIV1.0) (P=0.050) and forced expiratory volume in 1 s (FEV1.0) (P=0.045) in the E group, which exceeded the S groups results. Significant improvements in pulmonary function, breathing power, and chemoreflex ventilation threshold were observed in both groups, and there was a trend toward an improvement in swimming critical speed after 12 weeks of training (P=0.08). We concluded that although swim training results in attenuation of the ventilatory response to hypercapnia and in improvements in pulmonary function and sustainable breathing power, supplemental respiratory muscle training has no additional effect except on dynamic pulmonary function variables. 相似文献